Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107850422 | 10785042 | 2 | F | 200805 | 20160804 | 20150211 | 20160812 | EXP | US-GLAXOSMITHKLINE-A1077372A | GLAXOSMITHKLINE | 31.43 | YR | F | Y | 0.00000 | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107850422 | 10785042 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 20241 | 100 | MG | TABLET | BID | |||||||
| 107850422 | 10785042 | 2 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 100 MG, BID | U | UNKOWN | 20241 | 100 | MG | BID | |||||
| 107850422 | 10785042 | 3 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | U | 0 | |||||||||||
| 107850422 | 10785042 | 4 | C | WARFARIN | WARFARIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107850422 | 10785042 | 1 | Homocystinuria |
| 107850422 | 10785042 | 2 | Epilepsy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107850422 | 10785042 | Arthritis | |
| 107850422 | 10785042 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107850422 | 10785042 | 1 | 200805 | 0 | ||
| 107850422 | 10785042 | 2 | 20080508 | 0 |